Breakthrough Device Designation from the FDA

Breakthrough Device Designation from the FDA

  We are thrilled to announce that we just received a Breakthrough Device Designation from the United States Food and Drug Administration (FDA) for our novel hip cartilage repair technology. The intent of the Breakthrough Devices Program1 is to help patients have...
In WRAL Techwire

In WRAL Techwire

CytexOrtho is in the news! WRAL Techwire featured a Startup Spotlight article about CytexOrtho on Monday, August 8th, 2022.  According to WRAL: “Startup Spotlight is a regular feature in WRAL Techwire, bringing attention to promising emerging companies across the...
In Medical Textiles

In Medical Textiles

Today we are pleased to announce that our novel cartilage regeneration implant is the lead story in the November issue of Medical Textiles. This feature references the publication in Science Advances, where CytexOrtho scientists demonstrate cartilage restoration in...